{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:43:09Z","timestamp":1775169789532,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.2353\/jmoldx.2007.060191","type":"journal-article","created":{"date-parts":[[2007,8,9]],"date-time":"2007-08-09T20:49:51Z","timestamp":1186692591000},"page":"464-471","source":"Crossref","is-referenced-by-count":89,"title":["Application of a BRAF Pyrosequencing Assay for Mutation Detection and Copy Number Analysis in Malignant Melanoma"],"prefix":"10.1016","volume":"9","author":[{"given":"Cynthia","family":"Spittle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Renee","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine L.","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis A.","family":"Gimotty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Rappaport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia S.","family":"Brose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Letrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenhard","family":"Herlyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin H.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2353\/jmoldx.2007.060191_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.2353\/jmoldx.2007.060191_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jnci\/95.8.625","article-title":"BRAF mutation in papillary thyroid carcinoma","volume":"95","author":"Cohen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.2353\/jmoldx.2007.060191_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.2353\/jmoldx.2007.060191_bib4","first-page":"6451","article-title":"Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia","volume":"62","author":"Yuen","year":"2002","journal-title":"Cancer Res"},{"key":"10.2353\/jmoldx.2007.060191_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccr.2004.09.022","article-title":"Guilty as charged: B-RAF is a human oncogene","volume":"6","author":"Garnett","year":"2004","journal-title":"Cancer Cell"},{"key":"10.2353\/jmoldx.2007.060191_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1535-6108(03)00189-2","article-title":"BRAF as a potential therapeutic target in melanoma and other malignancies","volume":"4","author":"Tuveson","year":"2003","journal-title":"Cancer Cell"},{"key":"10.2353\/jmoldx.2007.060191_bib7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","article-title":"Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF","volume":"116","author":"Wan","year":"2004","journal-title":"Cell"},{"key":"10.2353\/jmoldx.2007.060191_bib8","first-page":"5198","article-title":"Suppression of BRAF(V599E) in human melanoma abrogates transformation","volume":"63","author":"Hingorani","year":"2003","journal-title":"Cancer Res"},{"key":"10.2353\/jmoldx.2007.060191_bib9","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/ijc.22144","article-title":"Raf kinases: oncogenesis and drug discovery","volume":"119","author":"Schreck","year":"2006","journal-title":"Int J Cancer"},{"key":"10.2353\/jmoldx.2007.060191_bib10","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1158\/0008-5472.CAN-03-3433","article-title":"V599EB-RAF is an oncogene in melanocytes","volume":"64","author":"Wellbrock","year":"2004","journal-title":"Cancer Res"},{"key":"10.2353\/jmoldx.2007.060191_bib11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jcp.2004.018655","article-title":"Detection of BRAF mutations in colorectal tumours and peritoneal washings using a mismatch ligation assay","volume":"58","author":"Busby","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.2353\/jmoldx.2007.060191_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.mcp.2004.05.004","article-title":"Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E","volume":"18","author":"Jarry","year":"2004","journal-title":"Mol Cell Probes"},{"key":"10.2353\/jmoldx.2007.060191_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.0303-6987.2005.00338.x","article-title":"Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction","volume":"32","author":"Turner","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.2353\/jmoldx.2007.060191_bib14","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1210\/jc.2003-032050","article-title":"Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer","volume":"89","author":"Xing","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.2353\/jmoldx.2007.060191_bib15","first-page":"S35","article-title":"Melanoma cell lines from different stages of progression and their biological and molecular analyses","volume":"7","author":"Satyamoorthy","year":"1997","journal-title":"Melanoma Res"},{"key":"10.2353\/jmoldx.2007.060191_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jmg.2003.016667","article-title":"Absence of BRAF mutations in UV-protected mucosal melanomas","volume":"41","author":"Edwards","year":"2004","journal-title":"J Med Genet"},{"key":"10.2353\/jmoldx.2007.060191_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1086\/497343","article-title":"High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs","volume":"77","author":"Slater","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.2353\/jmoldx.2007.060191_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","article-title":"NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing","volume":"16","author":"Edlundh-Rose","year":"2006","journal-title":"Melanoma Res"},{"key":"10.2353\/jmoldx.2007.060191_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2353\/jmoldx.2006.060082","article-title":"CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations","volume":"8","author":"Ogino","year":"2006","journal-title":"J Mol Diagn"},{"key":"10.2353\/jmoldx.2007.060191_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1525-1578(10)60571-5","article-title":"Sensitive sequencing method for KRAS mutation detection by pyrosequencing","volume":"7","author":"Ogino","year":"2005","journal-title":"J Mol Diagn"},{"key":"10.2353\/jmoldx.2007.060191_bib21","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1158\/0008-5472.CAN-03-3308","article-title":"An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays","volume":"64","author":"Zhao","year":"2004","journal-title":"Cancer Res"},{"key":"10.2353\/jmoldx.2007.060191_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00439-004-1163-1","article-title":"Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array","volume":"115","author":"Zhou","year":"2004","journal-title":"Hum Genet"},{"key":"10.2353\/jmoldx.2007.060191_bib23","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.2353\/jmoldx.2007.060191_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.leu.2404081","article-title":"JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders","volume":"20","author":"Quentmeier","year":"2006","journal-title":"Leukemia"},{"key":"10.2353\/jmoldx.2007.060191_bib25","first-page":"7233","article-title":"Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study","volume":"61","author":"Whitman","year":"2001","journal-title":"Cancer Res"},{"key":"10.2353\/jmoldx.2007.060191_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1385\/EP:16:2:099","article-title":"BRAF copy number gains in thyroid tumors detected by fluorescence in situ hybridization","volume":"16","author":"Ciampi","year":"2005","journal-title":"Endocr Pathol"},{"key":"10.2353\/jmoldx.2007.060191_bib27","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.1038\/sj.onc.1208152","article-title":"Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines","volume":"23","author":"Tanami","year":"2004","journal-title":"Oncogene"},{"key":"10.2353\/jmoldx.2007.060191_bib28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.humpath.2006.01.003","article-title":"BRAF and c-kit gene copy number in mutation-positive malignant melanoma","volume":"37","author":"Willmore-Payne","year":"2006","journal-title":"Hum Pathol"},{"key":"10.2353\/jmoldx.2007.060191_bib29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nature04304","article-title":"BRAF mutation predicts sensitivity to MEK inhibition","volume":"439","author":"Solit","year":"2006","journal-title":"Nature"},{"key":"10.2353\/jmoldx.2007.060191_bib30","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1158\/0008-5472.CAN-04-3625","article-title":"Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations","volume":"65","author":"Pohl","year":"2005","journal-title":"Cancer Res"},{"key":"10.2353\/jmoldx.2007.060191_bib31","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1158\/1078-0432.CCR-05-1729","article-title":"Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET\/PTC or BRAF mutations in vitro and in vivo","volume":"12","author":"Ouyang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.2353\/jmoldx.2007.060191_bib32","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1158\/1078-0432.CCR-05-2378","article-title":"BRAF is a therapeutic target in aggressive thyroid carcinoma","volume":"12","author":"Salvatore","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.2353\/jmoldx.2007.060191_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1158\/1078-0432.CCR-1118-3","article-title":"BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer","volume":"10","author":"Deng","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.2353\/jmoldx.2007.060191_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/B:FAME.0000039861.30651.c8","article-title":"Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer","volume":"3","author":"McGivern","year":"2004","journal-title":"Fam Cancer"},{"key":"10.2353\/jmoldx.2007.060191_bib35","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jmg.2004.020651","article-title":"BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing","volume":"41","author":"Domingo","year":"2004","journal-title":"J Med Genet"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157810604187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157810604187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T02:25:41Z","timestamp":1546655141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157810604187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1525157810604187"],"URL":"https:\/\/doi.org\/10.2353\/jmoldx.2007.060191","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}